Mangubat, Rudilyn L.
HRN: 25-18-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2024
CO-AMOXICLAV 625MG (TAB)
06/14/2024
06/20/2024
PO
1 Tab
BID
2nd Degree Perineal Laceration
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes